HSP90AA1 and cancer: On the basis of the ability of geraniin to bind and inhibit HSP90α activity, we evaluated its potential anti−proliferative or cytotoxic activity in HeLa (epithelial carcinoma) and Jurkat leukemia cancer cell lines.